{"queries":{"request":[{"totalResults":"4","searchTerms":"Natrecor"}]},"searchInformation":{"totalResults":"4"},"items":[{"title":"Scios Inc. Announces Agreement with Department of Justice Regarding NATRECOR®","link":"https://www.jnj.com/media-center/press-releases/scios-inc-announces-agreement-with-department-of-justice-regarding-natrecor","snippet":"Raritan, NJ (October 5, 2011) – Today Scios Inc. announced an agreement with the United States Department of Justice to resolve allegations of misbranding of NATRECOR® (nesiritide), a prescription medication for patients with heart failure. As part…","pagemap":{"Item":[{"date":"October 05, 2011"}]}},{"title":"Johnson & Johnson and its Subsidiaries, Janssen Pharmaceuticals, Inc. and Scios Inc., Conclude Previously Disclosed Settlement Agreements with U.S. Department of Justice and 45 States","link":"https://www.jnj.com/media-center/press-releases/johnson-johnson-and-its-subsidiaries-janssen-pharmaceuticals-inc-and-scios-inc-conclude-previously-disclosed-settlement-agreements-with-us-department-of-justice-and-45-states","snippet":"New Brunswick, NJ (November 4, 2013) – Johnson & Johnson and its subsidiaries, Janssen Pharmaceuticals, Inc. and Scios Inc., today announced they have finalized previously disclosed settlement agreements with the U.S. Department of Justice (DOJ) and…","pagemap":{"Item":[{"date":"November 04, 2013"}]}},{"title":"Janssen Pharmaceuticals, Inc. announces RISPERDAL® consumer protection settlement with 36 states and the District of Columbia","link":"https://www.jnj.com/media-center/press-releases/janssen-pharmaceuticals-inc-announces-risperdal-consumer-protection-settlement-with-36-states-and-the-district-of-columbia","snippet":"TITUSVILLE, NJ (August 30, 2012) Janssen Pharmaceuticals, Inc., a Johnson & Johnson company, announced a settlement and consent decree today with 36 states and the District of Columbia regarding previously disclosed allegations related to…","pagemap":{"Item":[{"date":"August 30, 2012"}]}},{"title":"Johnson & Johnson Expects to Incur Special Charge in Second Quarter for Previously Disclosed Legal Matters","link":"https://www.jnj.com/media-center/press-releases/johnson-johnson-expects-to-incur-special-charge-in-second-quarter-for-previously-disclosed-legal-matters","snippet":"New Brunswick, NJ – (June 8, 2012) – Johnson & Johnson today announced it expects to incur a special charge in the second quarter of 2012 of approximately $600 million to increase its accrual for the potential settlement of previously disclosed…","pagemap":{"Item":[{"date":"June 08, 2012"}]}}]}